Skip to main content
. 2012 Jul 11;2012(7):CD006534. doi: 10.1002/14651858.CD006534.pub2

Zhang 2006.

Methods Six‐week, (likely) randomised study.
Participants In‐ and out‐patients with depression according to CCMD‐III criteria.
Interventions Citalopram: 30 participants.
Maprotyline: 30 participants.
Citalopram dose range: 10‐40 mg/day (mean dose: 21.90 SD:6.93).
Maprotyline dose range: 25‐200 mg/day (mean dose: 141.52 SD: 30.4).
Outcomes Change in Hamilton Depression Rating Scale 17 Item (HDRS‐17) score from baseline to endpoint, number of patients who responded to treatment.
Notes Waiting for translation from Chinese to English (only abstract available in English).